The role of the glutamatergic system in the patogenesis and treatment of alcohol dependence;Rola układu glutaminianergicznego w patogenezie oraz terapii zespołu zależności alkoholowej

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 64, Issue , 2010, Pages 534-543

  Łukasik, Karina ^a   Pia̧tkowska, Karolina ^a   Pietrzak, Bogusława ^a  

^a UM w Łodzi ^*  (Poland)

Author keywords

Acamprosate; Alcohol dependence; Glutamatergic system; NMDA and AMPA KA receptors; Pharmacotherapy; Topiramate

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; DRUGS USED IN THE TREATMENT OF ADDICTION; GLUTAMATE RECEPTOR;

ALCOHOLISM; DRUG EFFECT; HUMAN; PATHOPHYSIOLOGY; REVIEW; TREATMENT OUTCOME;

ALCOHOL DETERRENTS; ALCOHOLISM; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; RECEPTORS, GLUTAMATE; TREATMENT OUTCOME;

EID: 79952721413     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Allgaier C: Ethanol sensitivity of NMDA receptors. Neurochem. Int., 2002;41:377-382 (Pubitemid 35232322)
2. Allgaier C, Scheibler P., Muller D., Feuerstein T. J., Illes P.: NMDA receptor characterization and subunit expression in rat cultured mesencephalic neurons. Br. J. Pharmacol., 1999;126:121-130 (Pubitemid 29041751)
3. Anders D. L., Blevins T., Sutton G., Chandler L. J., Woodward J. J.: Effects of c-Src tyrosine kinase on ethanol sensitivity of recombinant NMDA receptors expressed in HEK 293 cells. Alcohol. Clin. Exp. Res., 1999;23:357-362 (Pubitemid 29100413)
4. Anton R. F., O'Malley S. S., Ciraulo D. A., Cisler R. A., Couper D., Donovan D. M.: Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE Study: a randomized controlled trial. J. Am. Med. Assoc, 2006;295:2003-2017 (Pubitemid 44794003)
5. Backstrom P., Bachteler D., Koch S., Hyytia P., Spanagel R.: mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology, 2004;29:921-928 (Pubitemid 38526792)
6. Backstrom P., Hyytia P.: Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3, 4-DCPG. Eur. J. Pharmacol., 2005;528:110-118 (Pubitemid 41773660)
7. Baptista M. A., Martin-Fardon R., Weiss F.: Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer. J. Neurosci., 2004;24:4723-4727 (Pubitemid 38668196)
8. Boismare F., Daoust M., Moore N., Saligaut C, Lhuintre J. P., Chretien P.: A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved? Pharmacol. Biochem. Behav., 1984;21:787-789 (Pubitemid 15203861)
9. Bouza C, Angeles M., Munoz A., Amate J. M.: Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction, 2004;99:811-828 (Pubitemid 38869838)
10. Boyce-Rustay J. M., Wiedholz L. M., Millstein R. A., Carroll J., Murphy D. L., Daws L. C.: Ethanol-related behaviors in serotonin transporter knockout mice. Alcohol. Clin. Exp. Res., 2006;30:1957-1965 (Pubitemid 44749521)
11. Carta M., Ariwodola O. J., Weiner J. L., Valenzuela C. F.: Alcohol potently inhibits the kainite receptor-dependent excitatory drive of hippocampal interneurons. Proc. Natl. Acad. Sci. USA, 2003;100:6813-6818 (Pubitemid 36666662)
12. Castellano C, Cestari V., Ciamei A.: NMDA receptors and learning and memory processes. Current Drug Targets, 2001;2:273-283 (Pubitemid 32821470)
13. Chiamulera C, Epping-Jordan M. P, Zocchi A., Marcon C, Cottiny C, Tacconi S.: Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat. Neurosci., 2001;4:873-874 (Pubitemid 32801588)
14. Chick J., Aschauer H., Hornik K.: Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebocontrolled multicentre study with analysis by typology. Drug Alcohol. Depend., 2004;74:61-70 (Pubitemid 38457054)
15. Childress A. R., Mozley P. D., McElgin W., Fitzgerald J., Reivich M., O'Brien C. P.: Limbic activation turing cue-induced cocaine craving. Am. J. Psychiatry, 1999;156:11-18 (Pubitemid 29034874)
16. Chizh B. A., Headley P. M., Tzschentke T. M.: NMDA receptor antagonists as analgesics: focus on the NR2B subtype. Trends Pharmacol. Sci., 2001;22:636-642 (Pubitemid 33135525)
17. Conn P., Pin J. P.: Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol., 1997;37:205-237 (Pubitemid 27238875)
18. Costa E. T., Soto E. E., Cardoso R. A., Olivera D. S., Valenzuela C. F.: Acute effects of ethanol on kainate receptors in cultured hippocampal neurons. Alcohol. Clin. Exp. Res., 2000;24:220-225 (Pubitemid 30117425)
19. Cowen M. S., Djouma E., Lawrence A. J.: ThemGlu5 antagonist MTEP reduces ethanol self-administration in multiple strains of alcoholpreferring rats and regulates olfactory glutamatergic systems. J. Pharmacol. Exp. Ther., 2005;315:590-600 (Pubitemid 41500723)
20. Dahchour A., De Witte P., Bolo N., Nédélec J. F., Muzet M., Durbin P, Macher J. P.: Central effects of acamprosate. Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res., 1998;82:107-114 (Pubitemid 28341671)
21. Darstein M. B., Landwehrmeyer G. B., Feuerstein T. J.: Changes in NMDA receptor subunit gene expression in the rat brain following withdrawal from forced long-term ethanol intake. Naunyn Schmiedebergs Arch. Pharmacol., 2000;361:206-213 (Pubitemid 30062454)
22. Di Chara G.: Alcohol and dopamine. Alcohol Health Res. World, 1997;21:108-114
23. Di Ciano P., Everitt B. J.: Conditioned reinforcing properties of stimuli paired with self-administered cocaine, heroin or sucrose: implications for the persistence of addictive behaviour. Neuropharmacology, 2004;47:202-221
24. Dingledine R., Borges K., Bowie D., Traynelis S. F.: The glutamate receptor ion channels. Pharmacol. Rev., 1999;51:7-61 (Pubitemid 29113865)
25. Dongier M., Vachon L., Schwartz G.: Bromocriptine in the treatment of alcohol dependence. Alcohol. Clin. Exp. Res., 1991;15:970-977
26. Dundon W., Lynch K. G., Pettinati H. M., Lipkin C: Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy. Alcohol. Clin. Exp. Res., 2004;28:1065-1073 (Pubitemid 38955205)
27. Farook J. M., Lewis B., Littleton J. M., Barron S.: Topiramate attenuates the stress - induced increase in alcohol consumption and preference in male C57BL/6J mice. Physiol. Behav., 2009;96:189-193
28. Farook J. M., Morrell D. J., Lewis B., Littleton J. M., Barron S.: Topiramate (Topamax) reduces conditioning abstinence behaviours and handling - induced convulsions (HIC) after chronic administration of alcohol in Swiss - Webster mice. Alcohol Alcohol., 2007;42:296-300
29. Feeney G. F., Connor J. P., Young R. M., Tucker J., McPherson A.: Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy. Alcohol Alcohol., 2006;41:321-327
30. Floyd D. W., Jung K. Y., McCool B. A.: Chronic etanol ingestion facilitates N-methyl-D-aspartate receptor function and expression in rat lateral/ba so lateral amygdala neurons. J. Pharmacol. Exp. Ther., 2003;307:1020-1029 (Pubitemid 37494221)
31. Follesa P., Ticku M. K.: NMDA receptor upregulation: molecular studies in cultured mouse cortical neurons after chronic antagonist exposure. J. Neurosci., 1996;16:2172-2178 (Pubitemid 26154329)
32. Gabriel K. I., Cunningham C. L.: Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL/6J mice. Alcohol. Clin. Exp. Res., 2005;29:75-80 (Pubitemid 40129214)
33. Garbutt J. C., Kranzler H. R., O'Malley S. S., Gastfriend D. R., Pettinati H. M., Silverman B. L.: Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. J. Am. Med. Assoc, 2005;293:1617-1625 (Pubitemid 40471792)
34. Gass J. T., Olive M. F.: Glutamatergic substrates of drug addiction and alcoholism. Biochem. Pharmacol., 2008;75:218-265 (Pubitemid 350235390)
35. Gass J. T., Olive M. F.: Role of protein kinase C epsilon (PKCvarepsilon) in the reduction of ethanol reinforcement due to mGluR5 antagonism in the nucleus accumbens shell. Psychopharmacology, 2009;204:587-597
36. Gereau R. W., Heinemann S. F.: Role of protein kinase C phosphorylation in rapid desensitization of metabotropic glutamate receptor 5. Neuron, 1998;20:143-151 (Pubitemid 28078357)
37. Gibbs J. W., Sombati S., DeLorenzo R. J., Coulter D. A.: Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia, 2000;41:S10-S16
38. Hardy P. A., Chen W., Wilce P. A.: Chronic ethanol exposure and withdrawal influence NMDA receptor subunit and splice variant mRNA expression in the rat cerebral cortex. Brain Res., 1999;819:33-39 (Pubitemid 29225454)
39. Haugbol S. R., Ebert B., Ulrichsen J.: Upregulation of glutamate receptor subtypes during alcohol withdrawal in rats. Alcohol Alcohol., 2005;40:89-95 (Pubitemid 40347334)
40. Hedlund L., Wahlström G.: Acute and long term effects of buspirone treatments on voluntary ethanol intake in a rat model of alcoholism. Alcohol. Clin. Exp. Res., 1999;23:822-827 (Pubitemid 29256568)
41. Henniger M. S., Wotjak C. T., Holter S. M.: Long-term voluntary ethanol drinking increases expression of NMDA receptor 2B subunits in rat frontal cortex. Eur. J. Pharmacol, 2003;470:33-36 (Pubitemid 36638622)
42. Hermans E., Challiss R. A.: Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. Biochem. J., 2001;359:465-484 (Pubitemid 33063371)
43. Herrero A. I., Del Olmo N, Gonzalez-Escalada J. R., Solis J. M.: Two new actions of topiramate: inhibition of depolarizing GAB A (A)-mediated responses and activation of apotassium conductance. Neuropharmacology, 2002;42:210-220 (Pubitemid 34137024)
44. Higgins G. A., Ballard T. M., Kew J. N, Richards J. G., Kemp J. A., Adam G., Woltering T., Nakanishi S., Mutel V.: Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent. Neuropharmacology, 2004;46:907-917 (Pubitemid 38471944)
45. Hu X. J., Follesa P., Ticku M. K.: Chronic ethanol treatment produces a selective upregulation of the NMDA receptor subunit gene expression in mammalian cultured cortical neurons. Brain Res. Mol. Brain Res., 1996;36:211-218 (Pubitemid 26095580)
46. Jin C, Woodward J. J.: Effects of 8 different NR1 splice variants on the ethanol inhibition of recombinant NMDA receptors. Alcohol. Clin. Exp. Res., 2006;30:673-679
47. Johnson B. A.: Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment. CNS Drugs, 2004;18:1105-1118 (Pubitemid 40007493)
48. Johnson B. A.: Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem. Pharmacol., 2008;75:34-56 (Pubitemid 350235398)
49. Johnson B. A., Ait-Daoud N., Akhtar F. Z., Ma J. Z.: Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals. Arch. Gen. Psychiatry, 2004;61:905-912 (Pubitemid 39181080)
50. Johnson BA., Ait-Daoud N., Bowden C. L., Di Clemente C. C., Roache J. D., Lawson K., Javors M. A., Ma J. Z.: Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet, 2003;361:1677-1685 (Pubitemid 36577440)
51. Johnson B. A., O'Malley S. S., Ciraulo D. A., Roache J. D., Chambers R. A., Sarid-Segal O., Couper D.: Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol dependent subjects. J. Clin. Psychopharmacol., 2003;23:281-293 (Pubitemid 36807795)
52. Johnson B. A., Roache J. D., Javors M. A., Di Clemente C. C., Cloninger C. R., Prihoda T. J., Bordnick P. S., Ait-Daoud N., Hensler J.: Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial. J. Am. Med. Assoc, 2000;284:963-971 (Pubitemid 30659126)
53. Johnson B. A., Rosenthal N., Capece J. A., Wiegand F., Mao L., Beyers K., McKay A., Ait-Daoud N., Anton R. F., Ciraulo D. A., Kranzler H. R., Mann K., O'Malley S. S., Swift R. M.: Topiramate for the treating alcohol dependence: a randomized controlled trial. JAMA, 2007;298:1641-1651 (Pubitemid 47606653)
54. Kawabata S., Tsutsumi R., Kohara A., Yamaguchi T., Nakanishi S., Okuda M.: Control of calcium oscillation by phosphorylation of metabotropic glutamate receptors. Nature, 1996;383:89-92 (Pubitemid 26296467)
55. Kiefer F., Jahn H., Tarnaske T., Helwig H., Briken P., Holzbach R., Kampf P., Stracke R., Baehr M., Naber D., Wiedemann K.: Comparing and combinig naltrexone and acamprosat in relapse prevention of alcoholism: a double-blind, placebo-controled study. Arch. Gen. Psychiatry, 2003;60:92-99 (Pubitemid 36070869)
56. Koob G. F.: Neural mechanisms of drug reinforcement. Ann. N. Y. Acad. Sci., 1992;654:171-191
57. Kostowski W.: Neurofizjologiczne mechanizmy uzależnień: znaczenie zachowań impulsywnych. Farmakoterapia w Psychiatrii i Neurologii, 2005;2:93-102
58. Kranzler H. R., Pierucci-Lagha A., Feinn R., Hernandez-Avila C: Effects of ondansetron in early-versus late-onset alcoholics: a prospective, open-label study. Alcohol. Clin. Exp. Res., 2003;27:1150-1155 (Pubitemid 36890392)
59. Laaksonen E., Koski-Jännes A., Salaspuro M., Ahtinen H., Alho H.: A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol., 2008;43:53-61
60. Läck A. K., Diaz M. R., Chappell A., DuBois D. W., McCool B. A.: Chronic ethanol and withdrawal differentially modulate pre-and postsynaptic function at glutamatergic synapses in rat basolateral amygdala. J. Neurophysiol., 2007;98:3185-3196
61. Lecourtier L., Homayoun H., Tamagnan G., Moghaddam B.: Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex. Biol. Psychiatry, 2007;61:739-746 (Pubitemid 47374648)
62. Linden A. M., Shannon H., Baez M., Yu J. L., Koester A., Schoepp D. D.: Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice. Psychopharmacology, 2005;179:284-291 (Pubitemid 40576716)
63. Littleton J., Zieglgansberger W.: Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence. Am. J. Addict., 2003;12:S3-S11 (Pubitemid 36583412)
64. Lominac K. D., Kapasova Z., Hannun R. A., Patterson C, Middaugh L. D., Szumlinski K. K.: Behavioral and neurochemical interactions between Group 1 mGluR antagonists and ethanol: potential insight into their anti-addictive properties. Drug Alcohol Depend., 2006;85:142-156 (Pubitemid 44441668)
65. Lovinger D. M., White G., Weight F. F.: Ethanol inhibits NMDA activated ion current in hippocampal neurons. Science, 1989;243:1721-1724 (Pubitemid 19106970)
66. Lynch W. J., Johnson B. A.: Effects of topiramate on alcohol consumption in the rat. Alcohol. Clin. Exp. Res., 2007;31:261A
67. Łazarewicz J. W., Salińska E.: Ekscytotoksycznoś ć jako mechanizm neurodegeneracji i cel dla strategii terapeutycznych. Neuroprotekcja, XX Zimowa Szkoła Instytutu Farmakologii PAN, Mogilany 2003
68. Ma J. Z., Ait-Daoud N., Johnson B. A.: Topiramate reduces the harm of excessive drinking: implications for public health and primary care. Addiction, 2006;101:1561-1568 (Pubitemid 44527187)
69. Makarewicz D., Duszczyk M., Gadamski R., Danysz W., Lazarewicz J. W.: Neuroprotective potential of group I metabotropic glutamate receptor antagonists in two ischemic models. Neurochem. Int., 2006;48:485-490
70. Maldve R. E., Zhang T. A., Ferrani-Kile K., Schreiber S. S., Lippmann M. J., Snyder G. L., Fienberg A. A., Leslie S. W., Gonzales R. A., Morrisett R. A.: DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens. Nat. Neurosci., 2002;5:641-648 (Pubitemid 34742979)
71. Mann K., Lehert P., Morgan M. Y.: The efficacy of acamprosate in the maintenance of abstinence in alcohol dependent individuals: results of a meta-analysis. Alcohol. Clin. Exp. Res., 2004;28:51-63 (Pubitemid 38114023)
72. Marinelli P. W., Quirion R., Gianoulakis C: An in vivo profile of betaendorphin release in the arcuate nucleus and nucleus accumbens following exposure to stress or alcohol. Neuroscience, 2004;127:777-784 (Pubitemid 38993178)
73. Marutha Ravindran C. R., Ticku M. K.: Role of CpG islands in the upregulation of NMDA receptor NR2B gene expression following chronic ethanol treatment of cultured cortical neurons of mice. Neurochem. Int., 2005;46:313-327 (Pubitemid 40221845)
74. Mason B. J., Goodman A. M., Chabac S., Lehert P.: Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. J. Psychiatr. Res., 2006;40:383-393 (Pubitemid 43816589)
75. Mason G. A., Rezvani A. H., Grady D. R., Garbutt J. C.: The subchronic effects of the TRH analog TA-0910 and bromocriptine on alcohol preference in alcohol-preferring rats: development of tolerance and cross-tolerance. Alcohol. Clin. Exp. Res., 1994;18:1196-1201 (Pubitemid 24345530)
76. Meert T. F.: Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference. Alcohol, 1993;28:157-170 (Pubitemid 23169043)
77. Minami K., Gereau R. W.: Minami M., Heinemann S. F., Harris R. A., Effects of ethanol and anesthetics on type 1 and 5 metabotropic glutamate receptors expressed in Xenopus laevis oocytes. Mol. Pharm., 1998;53:148-156 (Pubitemid 28068383)
78. Miyakawa T., Yagi T., Kitazawa H., Yasuda M., Kawai N., Tsuboi K., Niki, H.: Fyn kinase as a determinant of ethanol sensitivity: relation to NMDA receptor function. Science, 1997;278:689-701
79. Naranjo C. A., Poulos C. X., Bremner K. E., Lanctot K. L.: Citalopram decreases desirability, liking, and consumption of alcohol in alcoholdependent drinkers. Clin. Pharmacol. Ther., 1992;51:729-739
80. Naranjo C. A., Sellers E. M., Sullivan J. T., Woodley D. V., Kadlec K., Sykora K.: The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin. Pharmacol. Ther., 1987;41:266-274 (Pubitemid 17034179)
81. Nie Z., Madamba S. G., Siggins G. R.: Ethanol inhibits glutamatergic neurotransmission in nucleus accumbens neurons by multiple mechanisms. J. Pharm. Exp. Ther., 1994;271:1566-1573 (Pubitemid 24382672)
82. Olive M. F., McGeehan A. J., Kinder J. R., McMahon T., Hodge C. W., Janak P. H., Messing R. O.: The mGluR5 antagonist 6-methyl-2-(phenylethynyl) pyridine decreases ethanol consumption via a protein kinase Ce-dependent mechanism. Mol. Pharmacol., 2005;67:349-355 (Pubitemid 40216726)
83. Ortiz J., Fitzgerald L. W., Charlton M., Lane S., Trevisan L., Guitart X., Shoemaker W., Duman R. S., Nestler E. J.: Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse, 1995;21:289-298 (Pubitemid 26039645)
84. Pettinati H. M., Volpicelli J. R., Kranzler H. R., Luck G., Rukstalis M. R., Cnaan A.: Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol. Clin. Exp. Res., 2000;24:1041-1049 (Pubitemid 30604324)
85. Popp R. L., Dertien J. S.: Actin depolymerization contributes to ethanol inhibition of NMDA receptors in primary cultured cerebellar granule cells. Alcohol, 2008;42:525-539
86. Powell B. J., Campbell J. L., Landon J. F., Liskow B. I., Thomas H. M., Nickel E. J., Dale T. M., Penick E. C., Samuelson S. D., Lacoursiere R. B.: A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders. Alcohol. Clin. Exp. Res., 1995;19:462-468
87. Putzke J., Spanagel R., Tolle T. R., Zieglgansberger W.: The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal. Eur. J. Pharmacol., 1996;317:39-48 (Pubitemid 26427011)
88. Rabe C. S., Tabakoff B.: Glycine site-directed agonists reverse the actions of ethanol at the N-methyl-D-aspartate receptor. Mol. Pharmacol., 1990;38:753-757
89. Rezayof A., Sharifi K., Zarrindast M. R., Rassouli Y.: Modulation of ethanol state-dependent learning by dorsal, hippocampal NMDA receptors in mice. Alcohol, 2008;42:667-674
90. Riedel G.: Function of metabotropic glutamate receptor in learning and memory. Trends Neurosci., 1996;19:219-224 (Pubitemid 26167813)
91. Roberto M., Bajo M., Crawford E., Madamba S. G., Siggins G. R.: Chronic ethanol exposure and protracted abstinence alter NMDA receptors in central amygdala. Neuropsychopharmacology, 2006;31:988-996
92. Roberto M., Schweitzer P., Madamba S. G., Stouffer D. G., Parsons L. H., Siggins G. R.: Acute and chronic ethanol alter glutamatergic transmission in rat central amygdala: an in vitro and in vivo analysis. J. Neurosci., 2004:1594-1603 (Pubitemid 38240954)
93. Roberts A. J., McDonald J. S., Heyser C. J., Kieffer B. L., Matthes H. W, Koob G. F., Gold L. H.: Mu-opioid receptor knockout mice do not selfadminister alcohol. J. Pharmacol. Exp. Ther. 2000;293:1002-1008 (Pubitemid 30417870)
94. Schroeder J. P., Overstreet D. H., Hodge C. W.: The mGluR5 antagonist MPEP decreases operant ethanol self-administration Turing maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats. Psychopharmacology (Berl), 2005;179:262-270 (Pubitemid 40576714)
95. Sevostianova N., Danysz W.: Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin test. Neuropharmacology, 2006;51:623-630 (Pubitemid 44215967)
96. Simonyi A., Christian M. R., Sun A. Y., Sun G. Y.: Chronic ethanolinduced subtype-and subregionspecific decrease in the mRNA expression of metabotropic glutamate receptors in rat hippocampus. Alcohol. Clin. Exp. Res., 2004;28:1419-1423 (Pubitemid 39238302)
97. Smothers C. T., Clayton R., Blevins T., Woodward J. J.: Ethanol sensitivity of recombinant human N-methyl-D aspartate receptors. Neurochem. Int., 2001;38:333-340 (Pubitemid 32012994)
98. Spooren W. P, Vassout A., Neijt H. C., Kuhn R., Gasparini F., Roux S., Porsolt R. D., Gentsch C: Anxiolytic like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl) pyridine in rodents. J. Pharmacol. Exp. Ther., 2000;295:1267-1275
99. Stobbs S. H., Ohran A. J., Lassen M. B., Allison D. W., Brwon J. E., Seffensen S. C.: Ethanol suppression of ventral tegmental area GABA neuron electrical transmission involves N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther., 2004;311:282-289 (Pubitemid 39287807)
100. Storvik M, Häkkinen M, Tupala E, Tiihonen J.: 5-HT (1A) receptors in the frontal cortical brain areas in Cloninger type 1 and 2 alcoholics measured by whole-hemisphere autoradiography. Alcohol Alcohol., 2009:44: 2-7
101. Taverna S., Sancini G., Mantegazza M., Franceschetti S, Avanzini G.: Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate. J. Pharmacol. Exp. Ther., 1999;288:960-968 (Pubitemid 29254132)
102. Watanabe T., Nakagawa T., Yamamoto R., Maeda A., Minami M., Satoh M.: Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal induced conditioned place aversion in rats. Jpn J. Pharmacol., 2002;88:399-406 (Pubitemid 34516565)
103. Weiss F., Mitchiner M., Bloom F. E., Koob G. F.: Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide. Psychopharmacology, 1990;101:178-186 (Pubitemid 20140215)
104. White H. S., Brown S. D., Woodhead J. H., Skeen G. A., Wolf H. H.: Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res., 1997;28:167-179 (Pubitemid 27400459)
105. Wirkner K., Eberts C, Poelchen W., Allgaier C, Illes P.: Mechanism of inhibition by ethanol of NMDA and AMPA receptor channel function in cultured rat cortical neurons. Naunyn Schmiedebergs Arch. Pharmacol., 2000;362:568-576
106. Xi Z. X., Baker D. A., Shen H., Carson D. S., Kalivas P. W.: Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens. J. Pharmacol. Exp. Ther., 2002;300:162-171 (Pubitemid 34028523)
107. Xi Z. X., Newman A. H., Gilbert J. G., Pak A. C., Peng X. Q., Ashby C. R., Gitajn L., Gardner E. L.: The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology, 2005;31:1383-1405
108. Yaka R., Tang K., Camarini R., Janak P. H., Ron D.: Fyn kinase and NR2B-containing NMDA receptors regulate acute ethanol sensitivity but not ethanol intake or conditioned reward. Alcohol. Clin. Exp. Res., 2003;27:1736-1742 (Pubitemid 37444359)
109. Zalewska-Kaszubska J., Gorska D., Dyr W., Czarnecka E.: Effect of acute administration of ethanol on betaendorphin plasma level in ethanol preferring and nonpreferring rats chronically treated with naltrexone. Pharmacol. Biochem. Behav., 2006;85:155-159 (Pubitemid 44772917)
110. Zhang X., Velumian A. A., Jones O. T., Carlen P. L.: Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia, 2000;41:52-60
111. Zhu W, Bie B., Pan Z. Z.: Involvement of non-NMDA glutamate receptors in central amygdala in synaptic actions of ethanol and ethanol-induced reward behavior. J. Neurosc, 2007;27:289-298 (Pubitemid 46106001)